Events

Part 1 of this series described the fact that ADPKD is a metabolic reprogramming disease, which may benefit from novel diet strategies such as a ketogenic diet. Part 2 of this 3- part series discussed the use of a Plant-Focused Ketogenic Diet (PFKD) program for improved ADPKD outcomes. In Part 3 of this series, we will focus on meal planning, meal preparation and a food demonstration describing a “day in the life” when following a Plant-Focused Ketogenic Diet.

Anemia is a well-known complication of chronic kidney disease (CKD) and the overall impact it has on patients who suffer from CKD is significant. In this informative webinar, renowned anemia expert, Dr Jay B Wish, will walk us through how managing patients with anemia in CKD has evolved over time and highlight recent scientific advancements that could potentially change the treatment landscape of anemia in CKD.

Anemia is a well-known complication of chronic kidney disease (CKD) and the overall impact it has on patients who suffer from CKD is significant. In this informative webinar, renowned anemia expert, Dr Jay B Wish, will walk us through how managing patients with anemia in CKD has evolved over time and highlight recent scientific advancements that could potentially change the treatment landscape of anemia in CKD.

This webinar will be a dialogue between two well-known Nephrologist who are experts in Chronic Kidney Disease (CKD) and Plant-based Nutrition. They will discuss the Concepts and Controversies of using a high-protein diet for weight loss and glycemic control in patients who have, or who are at risk of having, diabetic kidney disease (DKD).

This webinar will be a dialogue between two well-known Nephrologist who are experts in Chronic Kidney Disease (CKD) and Plant-based Nutrition. They will discuss the Concepts and Controversies of using a high-protein diet for weight loss and glycemic control in patients who have, or who are at risk of having, diabetic kidney disease (DKD).

Over the past 50 years there has been significant advancement in Polycystic Kidney Disease (PKD) research which has allowed for the translation of these findings into not only an increased awareness of the disease but also improvements in clinical management.

Over the past 50 years there has been significant advancement in Polycystic Kidney Disease (PKD) research which has allowed for the translation of these findings into not only an increased awareness of the disease but also improvements in clinical management.

In this webinar, NephU speakers discuss the role of the pharmacist in neurocritical care. Clinical pharmacists significantly contribute to the care of patients with hyponatremia by identifying patients at risk and the source of hyponatremia, monitor serum sodium concentration and advise on the selection of appropriate therapeutic agent, dosage and duration.

In this webinar, NephU speakers discuss the role of the pharmacist in neurocritical care. Clinical pharmacists significantly contribute to the care of patients with hyponatremia by identifying patients at risk and the source of hyponatremia, monitor serum sodium concentration and advise on the selection of appropriate therapeutic agent, dosage and duration.

Home dialysis modalities are increasingly emphasized in healthcare payment models and represent an important patient-centric option for renal replacement therapy. Join us for this informational discussion with Dr Ankur Shah and Dr Natasha Dave on important strategies that can be employed to establish and grow a successful peritoneal dialysis program.

Home dialysis modalities are increasingly emphasized in healthcare payment models and represent an important patient-centric option for renal replacement therapy. Join us for this informational discussion with Dr Ankur Shah and Dr Natasha Dave on important strategies that can be employed to establish and grow a successful peritoneal dialysis program.

Join us for an international panel discussion featuring members from the IgAN Foundation, expert nephrologists, patients & caregivers. Panelists will discuss living with IgAN; highlighting the similarities and differences in each patient’s journey, identify how providers can support patients, facilitate the patients’ understanding of IgAN management, and identify the current gaps in management.